Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Program Description

Gout is the most common form of chronic, inflammatory arthritis in the US, affecting approximately 9.2 million adults, with prevalence continuing to rise alongside obesity, hypertension, chronic kidney disease, and other metabolic comorbidities. Treatment typically involves urate-lowering therapies, yet many patients remain undertreated with therapies that fail to achieve target levels of serum urate. Uncontrolled gout leads to recurrent flares, chronic joint damage, and diminished quality of life. While emerging therapies offer new treatment strategies for patients with inadequately controlled or treatment-resistant disease, gaps in adherence and limited patient counseling remain key barriers to optimal outcomes. This activity will focus on the pharmacist’s role in supporting treatment adherence and counseling patients on therapy options and access, with strategies tailored specifically to the challenges of gout management. The webinar will examine guideline-based management strategies, clinical applications of novel agents, and patient-centered approaches for pharmacists to improve outcomes in patients with gout.

Target Audience: Community Pharmacist, Retail Pharmacist

Type of Activity: Application

Release date: November 21, 2025

Expiration date: November 21. 2026

Learner level: Foundational, Intermediate

Time to complete activity: 1.0 hour

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explain the epidemiology, risk factors, and comorbidities associated with gout, including key contributors to disease burden
• Analyze the potential clinical applications of next-generation therapies for patients with inadequately controlled or treatment-resistant gout
• Apply patient-centered strategies to support shared decision-making and treatment adherence in patients with gout

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-25-379-H01-P. The activity is available for CE credit through November 21, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Mary Barna Bridgeman, PharmD, BCPS, BCGP, has no relevant financial relationships with ineligible companies to disclose.

Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Victoria Chirdo; Susan Pordon; Brianna Winters; and Chloe Taccetta have no financial relationships with ineligible companies to disclose.

Pharmacy Times® Editorial Staff— Aislinn Antrim

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms